![](/img/cover-not-exists.png)
High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a177Lu-based CD22-specific radioimmunoconjugate and rituximab
T. Weber, B. Bötticher, W. Mier, M. Sauter, S. Krämer, K. Leotta, A. Keller, A. Schlegelmilch, L. Grosse-hovest, D. Jäger, U. Haberkorn, M. A. E. Arndt, J. KraussVolume:
43
Language:
english
Journal:
European Journal of Nuclear Medicine and Molecular Imaging
DOI:
10.1007/s00259-015-3175-6
Date:
March, 2016
File:
PDF, 1.03 MB
english, 2016